retatrutide and glucagon vs Tirzepatide: Key Differences Explained (2026) There's so much talk about

The active drug is identical, but the dose ceiling, label, and insurance coverage differ by brand

How to claim GLP-1 on HRA, FSA, or HSA documentation that works If your plan allows the expense, the documentation that gets a clean reimbursement is consistent across HRA, FSA, and HSA administrators: Prescription from a licensed clinician with the medication name, dose, and quantity

More recently, tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist, has demonstrated superior weight-reducing effects compared with both placebo and semaglutide, particularly in the SURMOUNT trials, with these benefits sustained for up to 72 weeks [79,80,81]

2019;181(6):R21134